CJC-1295 DAC peptide is a synthetic GHRH analog studied in endocrine and growth hormone axis laboratory research.

CJC-1295 DAC Peptide

Overview

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide structurally related to growth hormone-releasing hormone (GHRH), modified to alter peptide stability and circulation characteristics through albumin-binding interactions. Current CJC-1295 DAC peptide research focuses on GHRH-associated endocrine signaling and sustained signaling dynamics studied in controlled laboratory and in vitro environments. Research on CJC-1295 DAC peptide continues to expand into models evaluating extended peptide stability, GH/IGF-axis signaling, and coordinated cellular responses under controlled laboratory conditions. CJC-1295 DAC is frequently examined alongside other growth hormone secretagogue research compounds in experimental settings, particularly in models investigating sustained endocrine signaling. This compound is supplied strictly for research and analytical purposes and is not intended for human or veterinary use. CJC-1295 DAC peptide is frequently referenced in research literature examining GHRH-associated signaling under controlled laboratory conditions.

CJC-1295 DAC Peptide Receptor Interaction Research Context

In laboratory studies, CJC-1295 DAC has been evaluated for its interaction with GHRH receptor-associated signaling and albumin-binding-mediated stability, along with downstream GH/IGF-axis pathways, under controlled experimental conditions. These mechanisms are studied exclusively in experimental environments to better understand peptide-mediated signaling behavior at the molecular level.

Additional Research Considerations

Current investigations continue to assess endocrine signaling, extended binding interaction dynamics, and sustained signaling pattern behavior across different in vitro systems and analytical frameworks. Research efforts are also focused on understanding how variations in experimental design, concentration, and molecular stability may affect peptide behavior across different in vitro systems. Further scientific literature related to peptide-based research can be accessed through established databases such as PubMed, where ongoing studies and experimental findings are published.

Research Applications

• GHRH-associated receptor and endocrine signaling pathway analysis
• Extended peptide stability and binding interaction studies (DAC-modified constructs)
• GH/IGF-axis-related molecular signaling characterization
• Temporal and sustained signaling dynamic investigations in vitro
• Peptide structure-function analysis and assay development

Product Specifications

• Form: Lyophilized powder
• Purity: ≥99% (HPLC)
• Quantity: 5 mg
• Molecular Weight: 3,647.25 Da
• CAS Number: 446262-90-4
• Solubility: Soluble in compatible aqueous buffers
• Characterization: HPLC, Mass Spectrometry
• Testing: Third-party verified (COA available)

Storage and Handling

Store at −20 °C (−4 °F) or below. Store in the original vial, sealed and protected from light and moisture until use. Avoid repeated freeze-thaw cycles. Shelf life up to 24 months when stored lyophilized.

Related Research Compounds

CJC-1295 DAC is frequently studied alongside other research compounds in laboratory environments.

• Explore CJC-1295 (No DAC)
• View Sermorelin
• Explore Ipamorelin

This compound is part of our Growth Hormone & Secretagogue Research Peptides category, which includes a range of laboratory-grade peptide compounds studied in controlled environments.

Frequently Asked Questions

What is CJC-1295 DAC used for in research?

CJC-1295 DAC is studied in laboratory environments for its association with GHRH receptor signaling, extended peptide stability, and growth hormone axis research.

How is CJC-1295 DAC studied?

This compound is examined in controlled in vitro research settings, including cellular models and biochemical pathway analysis.

Is this product for human use?

No. This product is strictly for research use only.

Disclaimer, Intended Use & Terms of Sale

All content and information provided are for educational and research reference purposes only. This product and its associated data have not been evaluated by the U.S. Food and Drug Administration, and no claims are made regarding the diagnosis, treatment, cure, or prevention of any disease. No representations or warranties are made regarding safety, effectiveness, or outcomes. This product is intended strictly for in vitro laboratory research use only and is not for clinical use. It is not approved for human or animal administration and must not be used in food, dietary supplements, pharmaceuticals, cosmetics, or any consumer applications. By purchasing from Badger Compounds, the buyer affirms that they are a qualified researcher or institution with the appropriate training and facilities to handle research compounds in compliance with all applicable laws and regulations. All sales are final.